Recommendation based on LAURA Phase III trial results which showed Tagrisso extended median progression-free survival to more than three years
_256_384.jpg)
Emcure and Dhoni, through a video, urge everyone to be aware about symptoms of stroke and educate at least one person for identification of stroke and spread its awareness
Univar Solutions' pharmaceutical ingredients portfolio will be strengthened by the addition of a broad range of cellulose ethers and other excipient solutions
Total Income in Q2 FY25 stood at Rs. 532.18 crore
Opinion granted based on positive overall survival results from the IND.227/KEYNOTE-483 trial
Pharma CDMO business has posted a 40% YoY in Q2 driven by BD efforts and backed by macro tailwinds
Construction of the plant will commence in 2025 with first production expected to be in 2027
For Q2, Akums reported a consolidated total income of Rs. 1,046.6 crore
Emcure Pharmaceuticals has reported total income of Rs. 2,037.63 crores during the period ended September 30, 2024
Neuland Laboratories has reported total income of Rs. 315.17 crores during the period ended September 30, 2024
Subscribe To Our Newsletter & Stay Updated
